Re:Oxford University breakthrough on global COVID-19 vaccine
by wbl on Monday November 23, 2020 @10:09AM
(#25187480)
The usual course for a biotech is multiple raises as the drug progresses through trials and an early IPO. At each step investors see it as a surer shot.
[ Parent
| on HN ]
There are no comments on this comment yet.